Last reviewed · How we verify
Spherule-derived coccidioidin — Competitive Intelligence Brief
phase 3
Infectious Disease
Biologic
Live · refreshed every 30 min
Target snapshot
Spherule-derived coccidioidin (Spherule-derived coccidioidin) — Nielsen BioSciences, Inc.. Spherule-derived coccidioidin is a vaccine derived from the spherules of the Coccidioides fungus, which stimulates an immune response against the fungus.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Spherule-derived coccidioidin TARGET | Spherule-derived coccidioidin | Nielsen BioSciences, Inc. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Spherule-derived coccidioidin CI watch — RSS
- Spherule-derived coccidioidin CI watch — Atom
- Spherule-derived coccidioidin CI watch — JSON
- Spherule-derived coccidioidin alone — RSS
Cite this brief
Drug Landscape (2026). Spherule-derived coccidioidin — Competitive Intelligence Brief. https://druglandscape.com/ci/spherule-derived-coccidioidin. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab